'Pull every lev­er': Marks dou­bles down on ur­gency to im­prove gene ther­a­py man­u­fac­tur­ing

FDA’s bi­o­log­ics leader Pe­ter Marks has a warn­ing for gene ther­a­py man­u­fac­tur­ers and the health­care pay­ers that cov­er them: If they can’t stream­line man­u­fac­tur­ing in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER